Eugenics Redux: "Reproductive Benefit" as a Rationale for Newborn Screening

Area of Science:

• Genetics
• Public Health
• Bioethics

Background:

• Newborn screening programs have expanded to include conditions with questionable treatment efficacy.
• A new rationale for screening involves potential reproductive benefits for parents, identifying genetic conditions or carrier status in infants.
• This rationale has led to criticism, with newborn screening being accused of resembling state-sanctioned eugenics.

Purpose of the Study:

• To analyze the evolving rationales for newborn screening.
• To examine the ethical implications of using reproductive risk as a justification for newborn screening.
• To assess the impact of these ethical debates on the reputation of newborn screening programs.

Main Methods:

• Conceptual analysis of the historical development and ethical underpinnings of newborn screening.
• Review of literature discussing the rationale for expanded newborn screening and its societal perceptions.
• Examination of the 'state-sanctioned eugenics' critique in the context of reproductive benefits.

Main Results:

• The expansion of newborn screening has introduced new justifications, including parental reproductive benefits.
• Invoking reproductive risk has inadvertently exposed newborn screening to accusations of eugenics.
• This controversy has negatively impacted the public perception and reputation of newborn screening initiatives.

Conclusions:

• The rationale of reproductive benefit in newborn screening has created an ethical paradox, linking it to eugenics.
• This perceived association has caused significant reputational damage to established newborn screening programs.
• Careful consideration of ethical implications is crucial for maintaining public trust in newborn screening.